0001726399-18-000002.txt : 20180118 0001726399-18-000002.hdr.sgml : 20180118 20180118110850 ACCESSION NUMBER: 0001726399-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 EFFECTIVENESS DATE: 20180118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EquityZen Growth Technology Fund LLC - Series 175 CENTRAL INDEX KEY: 0001720460 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303542 FILM NUMBER: 18533284 BUSINESS ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 BUSINESS PHONE: (801) 419-0677 MAIL ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 FORMER COMPANY: FORMER CONFORMED NAME: EquityZen Growth Technology Fund LLC- Series 175 DATE OF NAME CHANGE: 20171023 D 1 primary_doc.xml X0708 D LIVE 0001720460 EquityZen Growth Technology Fund LLC - Series 175 10 West 18th St 7th Floor New York NY NEW YORK 10011-4618 (877) 490-6121 DELAWARE None EquityZen Growth Technology Fund LLC- Series 175 Limited Liability Company true 2017 LLC EquityZen Advisors 10 West 18th St 7th Floor New York NY NEW YORK 10011-4618 Executive Officer Director Manager Erin Rosenthal PO BOX 171305 Salt Lake City UT UTAH 84117 Executive Officer Attorney-in-Fact of the issuer LLC Assure Fund Management II PO BOX 171305 Salt Lake City UT UTAH 84117 Director Administrator Shriram Bhashyam 10 West 18th St 7th Floor New York NY NEW YORK 10011-4618 Executive Officer Director Manager Representative Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.1 false 2018-01-10 false true true false 10000 EquityZen Securities LLC 281820 EquityZen Securities LLC 281820 10 West 18th St 7th Floor New York NY NEW YORK 10011-4618 All States 122094 122094 0 false 7 6104 0 0 EquityZen Growth Technology Fund LLC - Series 175 Erin Rosenthal Erin Rosenthal Attorney-in-Fact of the issuer 2018-01-17